世界の軟骨変性市場予測2021年-2028年

◆英語タイトル:GLOBAL CARTILAGE DEGENERATION MARKET FORECAST 2021-2028

Inkwood Researchが発行した調査報告書(INK21N007)◆商品コード:INK21N007
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2021年8月
◆ページ数:225
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥666,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本市場調査レポートでは、軟骨変性の世界市場について調査・分析し、調査範囲・手法、エグゼクティブサマリー、市場動向、主要分析、処置別(関節置換術、軟骨形成、細胞ベース軟骨リサーフェシング、骨軟骨移植、メニスカス移植)分析、用途別(膝、腰、その他)分析、エンドユーザー別(外来手術センター、病院・専門クリニック、学術・研究機関)分析、地域別分析、競争状況などの項目を掲載しています。
・調査範囲・手法
・エグゼクティブサマリー
・市場動向
・主要分析
・軟骨変性の世界市場規模:処置別(関節置換術、軟骨形成、細胞ベース軟骨リサーフェシング、骨軟骨移植、メニスカス移植)
・軟骨変性の世界市場規模:用途別(膝、腰、その他)
・軟骨変性の世界市場規模:エンドユーザー別(外来手術センター、病院・専門クリニック、学術・研究機関)
・軟骨変性の世界市場規模:地域別
・競争状況

KEY FINDINGS
The global cartilage degeneration market is expected to advance with a CAGR of 4.64% over the forecasting years of 2021 to 2028. The market growth is primarily ascribed to factors such as degeneration of cartilage due to obesity, the prevalence of bone and joint-related diseases across the geriatric population, and the increasing number of sports injuries that damage cartilage and ligaments.

MARKET INSIGHTS
Cartilage is a smooth, connective tissue cushioning the meeting area of joints and bones. Cartilage degeneration can lead to chronic inflammation in the joints. The risk factors for cartilage denegation are accidental injury, weight, aging, sports injuries, or trauma to joints like knees or hips, among others. Cartilage regeneration is used to restore damaged cartilage. Some of these procedures include arthroscopy, autologous chondrocyte implantation, microfracture, and matrix-induced autologous chondrocyte implantation.

Players and athletes frequently suffer due to injuries during sports activities. These injuries have substantial potential to damage ligaments and cartilage. Therefore, an increasing number of sports injuries among players is expected to drive the growth of the cartilage degeneration market over the forecasting period. As per a study published by Stanford Children’s Health in 2020, an estimated 30 million children, as well as teenagers, participate in sports-related activities annually in the United States. Furthermore, according to the approximations issued by the institution, organized sports observe nearly 3.5 million injuries per year in the country.

REGIONAL INSIGHTS
The global cartilage degeneration market growth assessment entails the evaluation of the Asia-Pacific, North America, Europe, and the Rest of World. The Asia-Pacific is expected to grow with the highest CAGR over the forecasted years owing to the increased expenditure on public health care systems, the rising acceptance of sports activities among the younger generation, and the augmenting geriatric populace.

COMPETITIVE INSIGHTS
The competition among the tier 1 companies and tier 2 and tier 3 companies is on the rise within the global cartilage degeneration market. The threat of rivalry is also high among market participants in their respective segments. Moreover, vendors differentiate their products on the basis of cost, quality, and application.
Leading companies operating in the market are Smith & Nephew PLC, DePuy Synthes Companies, Arthrex Inc, Stryker Corporation, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

❖ レポートの目次 ❖

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SPORTS INJURIES DAMAGING CARTILAGE AND LIGAMENTS
3.1.2. DEGENERATION OF CARTILAGE DUE TO OBESITY
3.1.3. BONE AND JOINT-RELATED DISEASES IN THE GERIATRIC POPULATION
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF CARTILAGE REPAIR THERAPIES
3.2.2. LACK OF FAVORABLE REGULATORY ENVIRONMENT
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON CARTILAGE DEGENERATION MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. THREAT OF NEW ENTRY
4.3.2. THREAT OF SUBSTITUTION
4.3.3. BUYERS POWER
4.3.4. SUPPLIERS POWER
4.3.5. COMPETITIVE RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
5. MARKET BY PROCEDURE
5.1. JOINT REPLACEMENT
5.2. CHONDROPLASTY
5.3. CELL-BASED CARTILAGE RESURFACING
5.4. OSTEOCHONDRAL TRANSPLANT
5.5. MENISCUS TRANSPLANTS
5.6. OTHER PROCEDURES
6. MARKET BY APPLICATION
6.1. KNEE
6.2. HIPS
6.3. OTHER APPLICATIONS
7. MARKET BY END-USER
7.1. AMBULATORY SURGICAL CENTERS
7.2. HOSPITALS & SPECIALTY CLINICS
7.3. ACADEMIC & RESEARCH INSTITUTES
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. KEY GROWTH ENABLERS
8.1.3. KEY CHALLENGES
8.1.4. KEY PLAYERS
8.1.5. COUNTRY ANALYSIS
8.1.5.1. UNITED STATES
8.1.5.2. CANADA
8.2. EUROPE
8.2.1. MARKET SIZE & ESTIMATES
8.2.2. KEY GROWTH ENABLERS
8.2.3. KEY CHALLENGES
8.2.4. KEY PLAYERS
8.2.5. COUNTRY ANALYSIS
8.2.5.1. GERMANY
8.2.5.2. UNITED KINGDOM
8.2.5.3. FRANCE
8.2.5.4. ITALY
8.2.5.5. RUSSIA
8.2.5.6. POLAND
8.2.5.7. BELGIUM
8.2.5.8. REST OF EUROPE
8.3. ASIA-PACIFIC
8.3.1. MARKET SIZE & ESTIMATES
8.3.2. KEY GROWTH ENABLER
8.3.3. KEY CHALLENGES
8.3.4. KEY PLAYERS
8.3.5. COUNTRY ANALYSIS
8.3.5.1. CHINA
8.3.5.2. JAPAN
8.3.5.3. AUSTRALIA & NEW ZEALAND
8.3.5.4. INDIA
8.3.5.5. SOUTH KOREA
8.3.5.6. THAILAND
8.3.5.7. SINGAPORE
8.3.5.8. INDONESIA
8.3.5.9. REST OF ASIA-PACIFIC
8.4. REST OF WORLD
8.4.1. MARKET SIZE & ESTIMATES
8.4.2. KEY GROWTH ENABLERS
8.4.3. KEY CHALLENGES
8.4.4. KEY PLAYERS
8.4.5. REGIONAL ANALYSIS
8.4.5.1. LATIN AMERICA
8.4.5.2. MIDDLE EAST & AFRICA
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. ANIKA THERAPEUTICS INC
9.2.2. ARTHREX INC
9.2.3. B BRAUN MELSUNGEN AG
9.2.4. BIOTISSUE SA
9.2.5. CARTIHEAL INC
9.2.6. CONMED CORPORATION
9.2.7. DEPUY SYNTHES COMPANIES
9.2.8. OSIRIS THERAPEUTICS INC
9.2.9. RTI SURGICAL INC
9.2.10. SMITH & NEPHEW PLC
9.2.11. STRYKER CORPORATION
9.2.12. VERICEL CORPORATION
9.2.13. ZIMMER BIOMET HOLDINGS

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - CARTILAGE DEGENERATION
TABLE 2: NUMBER OF PERSONS AGED 65 YEARS OR OVER, BY GEOGRAPHIC REGION, 2019 AND 2050
TABLE 3: GLOBAL CARTILAGE DEGENERATION MARKET, BY PROCEDURE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 4: GLOBAL CARTILAGE DEGENERATION MARKET, BY PROCEDURE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 5: GLOBAL JOINT REPLACEMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 6: GLOBAL JOINT REPLACEMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 7: GLOBAL CHONDROPLASTY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 8: GLOBAL CHONDROPLASTY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 9: GLOBAL CELL-BASED CARTILAGE RESURFACING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 10: GLOBAL CELL-BASED CARTILAGE RESURFACING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 11: GLOBAL OSTEOCHONDRAL TRANSPLANT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 12: GLOBAL OSTEOCHONDRAL TRANSPLANT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 13: GLOBAL MENISCUS TRANSPLANTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 14: GLOBAL MENISCUS TRANSPLANTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 15: GLOBAL OTHER PROCEDURES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 16: GLOBAL OTHER PROCEDURES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 17: GLOBAL CARTILAGE DEGENERATION MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 18: GLOBAL CARTILAGE DEGENERATION MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 19: GLOBAL KNEE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 20: GLOBAL KNEE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 21: GLOBAL HIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 22: GLOBAL HIPS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 23: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 24: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 25: GLOBAL CARTILAGE DEGENERATION MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 26: GLOBAL CARTILAGE DEGENERATION MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 27: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 28: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 29: GLOBAL HOSPITALS & SPECIALTY CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 30: GLOBAL HOSPITALS & SPECIALTY CLINICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 31: GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 32: GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 33: GLOBAL CARTILAGE DEGENERATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 34: GLOBAL CARTILAGE DEGENERATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 35: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 36: NORTH AMERICA CARTILAGE DEGENERATION MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 37: LEADING PLAYERS OPERATING IN THE NORTH AMERICA CARTILAGE DEGENERATION MARKET
TABLE 38: EUROPE CARTILAGE DEGENERATION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 39: EUROPE CARTILAGE DEGENERATION MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 40: LEADING PLAYERS OPERATING IN EUROPE CARTILAGE DEGENERATION MARKET
TABLE 41: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 42: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 43: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CARTILAGE DEGENERATION MARKET
TABLE 44: REST OF WORLD CARTILAGE DEGENERATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 45: REST OF WORLD CARTILAGE DEGENERATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 46: LEADING PLAYERS OPERATING IN REST OF WORLD CARTILAGE DEGENERATION MARKET
TABLE 47: LIST OF MERGERS & ACQUISITIONS
TABLE 48: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 49: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 50: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES


LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: GLOBAL CARTILAGE DEGENERATION MARKET, BY PROCEDURE, IN 2020
FIGURE 6: GLOBAL CARTILAGE DEGENERATION MARKET, BY JOINT REPLACEMENT, 2021-2028 (IN $ MILLION)
FIGURE 7: GLOBAL CARTILAGE DEGENERATION MARKET, BY CHONDROPLASTY, 2021-2028 (IN $ MILLION)
FIGURE 8: GLOBAL CARTILAGE DEGENERATION MARKET, BY CELL-BASED CARTILAGE RESURFACING, 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL CARTILAGE DEGENERATION MARKET, BY OSTEOCHONDRAL TRANSPLANT, 2021-2028 (IN $ MILLION)
FIGURE 10: GLOBAL CARTILAGE DEGENERATION MARKET, BY MENISCUS TRANSPLANTS, 2021-2028 (IN $ MILLION)
FIGURE 11: GLOBAL CARTILAGE DEGENERATION MARKET, BY OTHER PROCEDURES, 2021-2028 (IN $ MILLION)
FIGURE 12: GLOBAL CARTILAGE DEGENERATION MARKET, BY APPLICATION, IN 2020
FIGURE 13: GLOBAL CARTILAGE DEGENERATION MARKET, BY KNEE, 2021-2028 (IN $ MILLION)
FIGURE 14: GLOBAL CARTILAGE DEGENERATION MARKET, BY HIPS, 2021-2028 (IN $ MILLION)
FIGURE 15: GLOBAL CARTILAGE DEGENERATION MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL CARTILAGE DEGENERATION MARKET, BY END-USER, IN 2020
FIGURE 17: GLOBAL CARTILAGE DEGENERATION MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)
FIGURE 18: GLOBAL CARTILAGE DEGENERATION MARKET, BY HOSPITALS & SPECIALTY CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 19: GLOBAL CARTILAGE DEGENERATION MARKET, BY ACADEMIC & RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 20: NORTH AMERICA CARTILAGE DEGENERATION MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 21: UNITED STATES CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)
FIGURE 22: CANADA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)
FIGURE 23: EUROPE CARTILAGE DEGENERATION MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 24: GERMANY CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)
FIGURE 25: UNITED KINGDOM CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)
FIGURE 26: FRANCE CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)
FIGURE 27: ITALY CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)
FIGURE 28: RUSSIA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)
FIGURE 29: POLAND CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)
FIGURE 30: BELGIUM CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)
FIGURE 31: REST OF EUROPE CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)
FIGURE 32: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 33: CHINA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)
FIGURE 34: JAPAN CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)
FIGURE 35: AUSTRALIA & NEW ZEALAND CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)
FIGURE 36: INDIA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)
FIGURE 37: SOUTH KOREA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)
FIGURE 38: THAILAND CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)
FIGURE 39: SINGAPORE CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)
FIGURE 40: INDONESIA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)
FIGURE 41: REST OF ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)
FIGURE 42: REST OF WORLD CARTILAGE DEGENERATION MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 43: LATIN AMERICA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)
FIGURE 44: MIDDLE EAST & AFRICA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の軟骨変性市場予測2021年-2028年(GLOBAL CARTILAGE DEGENERATION MARKET FORECAST 2021-2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆